Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans

Clinical Immunology

Volumn 117, Issue 2, 2005, Pages 152-160

  Fischer, Christian P ^a   Perstrup, Lisbeth B ^b   Berntsen, Annika ^b   Eskildsen, Peter ^b   Pedersen, Bente K ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b KØGE HOSPITAL   (Denmark)

Author keywords

Cytokines; Epidemiology; Inflammation; Insulin resistance; Obesity; Type 2 diabetes

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 18; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL ANALYSIS;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; INTERLEUKIN-18; INTERLEUKIN-6; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 26044457651     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2005.07.008     Document Type: Article

References (46)

1. M. Recasens, A. Lopez-Bermejo, W. Ricart, J. Vendrell, R. Casamitjana, and J.M. Fernandez-Real An inflammation score is better associated with basal than stimulated surrogate indexes of insulin resistance J. Clin. Endocrinol. Metab. 90 2005 112 116
2. J.M. Fernandez-Real, M. Broch, J. Vendrell, C. Gutierrez, R. Casamitjana, M. Pugeat, C. Richart, and W. Ricart Interleukin-6 gene polymorphism and insulin sensitivity Diabetes 49 2000 517 520
3. Y. Mishima, A. Kuyama, A. Tada, K. Takahashi, T. Ishioka, and M. Kibata Relationship between serum tumor necrosis factor-[alpha] and insulin resistance in obese men with Type 2 diabetes mellitus Diabetes Res. Clin. Pract. 52 2001 119 123
4. S.-Y. Lin, Y.-Y. Wang, and W.-H.H. Sheu Increased serum soluble tumor necrosis factor receptor levels are associated with insulin resistance in liver cirrhosis Metabolism 53 2004 922 926
5. T. McLaughlin, F. Abbasi, C. Lamendola, L. Liang, G. Reaven, P. Schaaf, and P. Reaven Differentiation between obesity and insulin resistance in the association with C-reactive protein Circulation 106 2002 2908 2912
6. V. Mohamed-Ali, S. Goodrick, A. Rawesh, D.R. Katz, J.M. Miles, J.S. Yudkin, S. Klein, and S.W. Coppack Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-{alpha}, in vivo J. Clin. Endocrinol. Metab. 82 1997 4196 4200
7. G.S. Hotamisligil, P. Arner, J.F. Caro, R.L. Atkinson, and B.M. Spiegelman Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance J. Clin. Invest. 95 1995 2409 2415
8. J.S. Yudkin, C.D.A. Stehouwer, J.J. Emeis, and S.W. Coppack C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler. Thromb. Vasc. Biol. 19 1999 972 978
9. G. Winkler, S. Kiss, L. Keszthelyi, Z. Sapi, I. Ory, F. Salamon, M. Kovacs, P. Vargha, O. Szekeres, G. Speer, I. Karadi, M. Sikter, E. Kaszas, O. Dworak, G. Gero, and K. Cseh Expression of tumor necrosis factor (TNF)-alpha protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-alpha, soluble serum TNF-receptor-2 concentrations and C-peptide level Eur. J. Endocrinol. 149 2003 129 135
10. A.E. Hak, C.D.A. Stehouwer, M.L. Bots, K.H. Polderman, C.G. Schalkwijk, I.C.D. Westendorp, A. Hofman, and J.C.M. Witteman Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women Arterioscler. Thromb. Vasc. Biol. 19 1999 1986 1991
11. A.L. Carey, C.R. Bruce, M. Sacchetti, M.J. Anderson, D.B. Olsen, B. Saltin, J.A. Hawley, and M.A. Febbraio Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness Diabetologia 47 2004 1029 1037
12. R. Retnakaran, A.J.G. Hanley, N. Raif, P.W. Connelly, M. Sermer, and B. Zinman C-reactive protein and gestational diabetes: the central role of maternal obesity J. Clin. Endocrinol. Metab. 88 2003 3507 3512
13. H. Okamura, H. Tsutsi, T. Komatsu, M. Yutsudo, A. Hakura, T. Tanimoto, K. Torigoe, T. Okura, Y. Nukada, and K. Hattori Cloning of a new cytokine that induces IFN-gamma production by T cells Nature 378 1995 88 91
14. C.A. Dinarello IL-18: a TH1-inducing, proinflammatory cytokine and new member of the IL-1 family J. Allergy Clin. Immunol. 103 1999 11 24
15. J.K. Lee, S.H. Kim, E.C. Lewis, T. Azam, L.L. Reznikov, and C.A. Dinarello Differences in signaling pathways by IL-1{beta} and IL-18 PNAS 101 2004 8815 8820
16. K.F. Nolan, D.R. Greaves, and H. Waldmann The human interleukin 18 GeneIL18 maps to 11q22.2-q22.3, closely linked to the DRD2 gene locus and distinct from mapped IDDM loci Genomics 51 1998 161 163
17. J.A. Gracie, S.E. Robertson, and I.B. McInnes Interleukin-18 J. Leukocyte Biol. 73 2003 213 224
18. Y. Gu, K. Kuida, H. Tsutsui, G. Ku, K. Hsiao, M.A. Fleming, N. Hayashi, K. Higashino, H. Okamura, K. Nakanishi, M. Kurimoto, T. Tanimoto, R.A. Flavell, V. Sato, M.W. Harding, D.J. Livingston, and M.S.S. Su Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme Science 275 1997 206 209
19. H. Tsutsui, N. Kayagaki, K. Kuida, H. Nakano, N. Hayashi, K. Takeda, K. Matsui, S. Kashiwamura, T. Hada, S. Akira, H. Yagita, H. Okamura, and K. Nakanishi Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice Immunity 11 1999 359 367
20. S. Kashiwamura, H. Ueda, and H. Okamura Roles of interleukin-18 in tissue destruction and compensatory reactions J. Immunother. 25 Suppl. 1 2002 S4 S11
21. C.A. Dinarello, D. Novick, A.J. Puren, G. Fantuzzi, L. Shapiro, H. Muhl, D.Y. Yoon, L.L. Reznikov, S.H. Kim, and M. Rubinstein Overview of interleukin-18: more than an interferon-gamma inducing factor J. Leukocyte Biol. 63 1998 658 664
22. S. Blankenberg, L. Tiret, C. Bickel, D. Peetz, F. Cambien, J. Meyer, and H.J. Rupprecht For the atherogene investigators, interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina Circulation 106 2002 24 30
23. S. Frigerio, G.A. Hollander, and U. Zumsteg Functional IL-18 Is produced by primary pancreatic mouse islets and NIT-1 beta cells and participates in the progression towards destructive insulitis Horm. Res. 57 2002 94 104
24. Y. Oikawa, A. Shimada, A. Kasuga, J. Morimoto, T. Osaki, H. Tahara, T. Miyazaki, F. Tashiro, E. Yamato, J.i. Miyazaki, and T. Saruta Systemic administration of IL-18 promotes diabetes development in young nonobese diabetic mice J. Immunol. 171 2003 5865 5875
25. A. Kretowski, K. Mironczuk, A. Karpinska, U. Bojaryn, M. Kinalski, Z. Puchalski, and I. Kinalska Interleukin-18 promoter polymorphisms in type 1 diabetes Diabetes 51 2002 3347 3349
26. M. Kawashima, M. Yamamura, M. Taniai, H. Yamauchi, T. Tanimoto, M. Kurimoto, S. Miyawaki, T. Amano, T. Takeuchi, and H. Makino Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease Arthritis Rheum. 44 2001 550 560
27. Y. Aso, K.i. Okumura, K. Takebayashi, S. Wakabayashi, and T. Inukai Relationships of plasma interleukin-18 concentrations to hyperhomocysteinemia and carotid intimal-media wall thickness in patients with type 2 diabetes Diabetes Care 26 2003 2622 2627
28. Y. Moriwaki, T. Yamamoto, Y. Shibutani, E. Aoki, Z. Tsutsumi, S. Takahashi, H. Okamura, M. Koga, M. Fukuchi, and T. Hada Elevated levels of interleukin-18 and tumor necrosis factor-[alpha] in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy Metabolism 52 2003 605 608
29. K. Esposito, R. Marfella, and D. Giugliano Plasma interleukin-18 concentrations are elevated in type 2 diabetes Diabetes Care 27 2004 272
30. K. Esposito, A. Pontillo, M. Ciotola, C. Di Palo, E. Grella, G. Nicoletti, and D. Giugliano Weight loss reduces interleukin-18 levels in obese women J. Clin. Endocrinol. Metab. 87 2002 3864 3866
31. J. Hung, B.M. McQuillan, C.M.L. Chapman, P.L. Thompson, and J.P. Beilby Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance Arterioscler. Thromb. Vasc. Biol. 2005 01
32. H.F. Escobar-Morreale, J.I. Botella-Carretero, G. Villuendas, J. Sancho, and J.L. San Millan Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity J. Clin. Endocrinol. Metab. 89 2004 806 811
33. B. Lindegaard, A.B. Hansen, J. Gerstoft, and B.K. Pedersen High plasma level of interleukin-18 in HIV-infected subjects with lipodystrophy J. Acquired Immune Defic. Syndr. 36 2004 588 593
34. K.G. Alberti, and P.Z. Zimmet Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabetes Med. 15 1998 539 553
35. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
36. T.M. Wallace, J.C. Levy, and D.R. Matthews Use and abuse of HOMA modeling Diabetes Care 27 2004 1487 1495
37. K. Esposito, A. Pontillo, C. Di Palo, G. Giugliano, M. Masella, R. Marfella, and D. Giugliano Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial JAMA 289 2003 1799 1804
38. S.O. Olusi, A. Al Awadhi, and M. Abraham Relations of serum interleukin 18 levels to serum lipid and glucose concentrations in an apparently healthy adult population Horm. Res. 60 2003 29 33
39. B. Lindegaard, A.B. Hansen, H. Pilegaard, P. Keller, J. Gerstoft, and B.K. Pedersen Adipose tissue expression of IL-18 and HIV-associated lipodystrophy AIDS 18 2004 1956 1958
40. S.P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R.L. Leibel, and A.W. Ferrante Jr. Obesity is associated with macrophage accumulation in adipose tissue J. Clin. Invest. 112 2003 1796 1808
41. B. Emanuelli, P. Peraldi, C. Filloux, C. Chavey, K. Freidinger, D.J. Hilton, G.S. Hotamisligil, and E. Van Obberghen SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice J. Biol. Chem. 276 2001 47944 47949
42. G.S. Hotamisligil, P. Peraldi, A. Budavari, R. Ellis, M.F. White, and B.M. Spiegelman IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance Science 271 1996 665 668
43. K. Esposito, F. Nappo, R. Marfella, G. Giugliano, F. Giugliano, M. Ciotola, L. Quagliaro, A. Ceriello, and D. Giugliano Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress Circulation 106 2002 2067 2072
44. D.J. Herzyk, P.J. Bugelski, T.K. Hart, and P.J. Wier Preclinical safety of recombinant human interleukin-18 Toxicol. Pathol. 31 2003 554 561
45. J.A. Gracie Interleukin-18 as a potential target in inflammatory arthritis Clin. Exp. Immunol. 136 2004 402 404
46. C.A. Dinarello Novel targets for interleukin 18 binding protein Ann. Rheum. Dis. 60 2001 18iii 24iii